 - Subject uses a CYP3A4 metabolized substrate that can prolong the QT interval, e.g., astemizole, bepridil, cisapride, dofetilide, levacetylmethadol levomethadyl, mizolastine, pimozide, quinidine, sertindole and terfenadine. 